BI1015550

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI1015550, covering 2025-11-28 to 2025-11-28. Get the full timeline:

Most recent: Clinical Trial Update: This Study Tests How Healthy Men Tolerate Different Doses of BI1015550. The Study Also Tests How BI 1015550 is Taken up by the Body [Phase 1]

See pricing